Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride

Summary

Magnesium iron hydroxycarbonate is a phosphate binder that absorbs phosphate from food, reducing the amount that the body can absorb. The purpose of this study is to assess the efficacy of magnesium iron hydroxycarbonate in subjects requiring haemodialysis, compared with a marketed phosphate binder, sevelamer hydrochloride.

Timeline

Start

2009-07

Primary completion

2011-09

Completion

2011-10

Drugs

Indications